The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2025
Synopsis
Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
The global Chronic Plaque Psoriasis Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Plaque Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Plaque Psoriasis Therapeutics.
Report Scope
The Chronic Plaque Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Plaque Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Plaque Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Novartis International
Pfizer
Merck
Astelllas Pharma
GlaxoSmithKline
Segment by Type
Clinical
Non-Clinical
Inactive
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Plaque Psoriasis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
The global Chronic Plaque Psoriasis Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Plaque Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Plaque Psoriasis Therapeutics.
Report Scope
The Chronic Plaque Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Plaque Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Plaque Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Novartis International
Pfizer
Merck
Astelllas Pharma
GlaxoSmithKline
Segment by Type
Clinical
Non-Clinical
Inactive
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Plaque Psoriasis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Clinical
1.2.3 Non-Clinical
1.2.4 Inactive
1.3 Market by Application
1.3.1 Global Chronic Plaque Psoriasis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Plaque Psoriasis Therapeutics Market Perspective (2019-2030)
2.2 Chronic Plaque Psoriasis Therapeutics Growth Trends by Region
2.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Plaque Psoriasis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Chronic Plaque Psoriasis Therapeutics Market Dynamics
2.3.1 Chronic Plaque Psoriasis Therapeutics Industry Trends
2.3.2 Chronic Plaque Psoriasis Therapeutics Market Drivers
2.3.3 Chronic Plaque Psoriasis Therapeutics Market Challenges
2.3.4 Chronic Plaque Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Plaque Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Plaque Psoriasis Therapeutics Revenue
3.4 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Plaque Psoriasis Therapeutics Revenue in 2023
3.5 Chronic Plaque Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Plaque Psoriasis Therapeutics Market Size (2019-2030)
6.2 North America Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024)
6.4 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size (2019-2030)
7.2 Europe Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size (2019-2030)
9.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Introduction
11.1.4 Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Detail
11.2.2 Novartis International Business Overview
11.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Introduction
11.2.4 Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.2.5 Novartis International Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Introduction
11.3.4 Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Plaque Psoriasis Therapeutics Introduction
11.4.4 Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Astelllas Pharma
11.5.1 Astelllas Pharma Company Detail
11.5.2 Astelllas Pharma Business Overview
11.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Introduction
11.5.4 Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.5.5 Astelllas Pharma Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Clinical
Table 3. Key Players of Non-Clinical
Table 4. Key Players of Inactive
Table 5. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Chronic Plaque Psoriasis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Chronic Plaque Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region (2019-2024)
Table 9. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region (2025-2030)
Table 11. Chronic Plaque Psoriasis Therapeutics Market Trends
Table 12. Chronic Plaque Psoriasis Therapeutics Market Drivers
Table 13. Chronic Plaque Psoriasis Therapeutics Market Challenges
Table 14. Chronic Plaque Psoriasis Therapeutics Market Restraints
Table 15. Global Chronic Plaque Psoriasis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2023)
Table 18. Ranking of Global Top Chronic Plaque Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
Table 22. Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Plaque Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Chronic Plaque Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbvie Company Detail
Table 48. Abbvie Business Overview
Table 49. Abbvie Chronic Plaque Psoriasis Therapeutics Product
Table 50. Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Abbvie Recent Development
Table 52. Novartis International Company Detail
Table 53. Novartis International Business Overview
Table 54. Novartis International Chronic Plaque Psoriasis Therapeutics Product
Table 55. Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Novartis International Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Chronic Plaque Psoriasis Therapeutics Product
Table 60. Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Merck Company Detail
Table 63. Merck Business Overview
Table 64. Merck Chronic Plaque Psoriasis Therapeutics Product
Table 65. Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Astelllas Pharma Company Detail
Table 68. Astelllas Pharma Business Overview
Table 69. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product
Table 70. Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Astelllas Pharma Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Plaque Psoriasis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Plaque Psoriasis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Clinical Features
Figure 4. Non-Clinical Features
Figure 5. Inactive Features
Figure 6. Global Chronic Plaque Psoriasis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Plaque Psoriasis Therapeutics Report Years Considered
Figure 12. Global Chronic Plaque Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Chronic Plaque Psoriasis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players in 2023
Figure 16. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2023
Figure 18. North America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Share by Region (2019-2030)
Figure 32. China Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbvie Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 47. Novartis International Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 50. Astelllas Pharma Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
